CAL-33Homo sapiens (Human)Cancer cell line

Also known as: Centre Antoine Lacassagne-33, CAL-SCC-33, CAL33, CAL 33, Cal-33

🤖 AI SummaryBased on 8 publications

Quick Overview

CAL-33 is a human cancer cell line used in research for various cancers.

Detailed Summary

CAL-33 is a human cancer cell line derived from squamous cell carcinoma. It is widely used in cancer research for studying tumor biology, drug development, and genetic mutations. The cell line has been utilized in multiple studies to investigate the molecular mechanisms of cancer and to test therapeutic strategies. CAL-33 is known for its genetic instability and has been involved in studies related to cell cycle regulation, apoptosis, and cancer progression. It is also used to evaluate the efficacy of anticancer drugs and to understand the genetic basis of cancer resistance.
Generated on 6/16/2025

Basic Information

Database IDCVCL_1108
SpeciesHomo sapiens (Human)
Tissue SourceOral cavity, tongue[UBERON:UBERON_0001723]

Donor Information

Age69
Age CategoryAdult
SexMale

Disease Information

DiseaseSquamous cell carcinoma of the oral tongue
LineageHead and Neck
SubtypeOral Cavity Squamous Cell Carcinoma
OncoTree CodeOCSC

DepMap Information

Source TypeDSMZ
Source IDACH-000518_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Arg175His (c.524G>A)UnspecifiedSomatic mutation acquired during proliferationfrom parent cell line YCC-3
MutationSimpleTMPRSS2p.Gly8Val (c.23G>T) (c.-57+99G>T)Heterozygous-PubMed=34339474

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X,Y
CSF1PO
11,12
D10S1248
13,16
D12S391
15,18
D13S317
8,13
D16S539
11
D18S51
14
D19S433
14,15.2
D1S1656
16,16.3
D21S11
29,30
D22S1045
16
D2S1338
20,25
D2S441
14
D3S1358
17
D5S818
11,12
D7S820
8,10
D8S1179
13
DYS391
11
FGA
21,22
Penta D
12,13
Penta E
7,15
TH01
9,9.3
TPOX
8
vWA
17
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Fanconi anemia-isogenic head and neck cancer cell line pairs: a basic and translational science resource.

Smogorzewska A., Monnat R.J. Jr.

Int. J. Cancer 153:183-196(2023).

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

Identification of cell lines CL-14, CL-40 and CAL-51 as suitable models for SARS-CoV-2 infection studies.

Safranko Z.M., Kurolt I.-C., Markotic A., Cicin-Sain L., Steenpass L.

PLoS ONE 16:E0255622-E0255622(2021).

Quantitative proteomics of the Cancer Cell Line Encyclopedia.";

Sellers W.R., Gygi S.P.

Cell 180:387-402.e16(2020).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens.

Stronach E.A., Saez-Rodriguez J., Yusa K., Garnett M.J.

Nature 568:511-516(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

The head and neck cancer cell oncogenome: a platform for the development of precision molecular therapies.

Zaida M., Delic N.C., Samuels Y., Lyons J.G., Gutkind J.S.

Oncotarget 5:8906-8923(2014).

Establishment and molecular cytogenetic characterization of a cell culture model of head and neck squamous cell carcinoma (HNSCC).

Huber R., Walch A., Zitzelsberger H.

Genes (Basel) 1:388-412(2010).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.

Haber D.A.

Cancer Res. 70:2158-2164(2010).

Signatures of mutation and selection in the cancer genome.";

Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.

Nature 463:893-898(2010).

Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: establishment, characterization and response to cytotoxic treatment.

Courdi A.

Eur. J. Cancer Clin. Oncol. 24:1445-1455(1988).

Characterization of a new surface epitope specific for human epithelial cells defined by a monoclonal antibody and application to tumor diagnosis.

Lalanne C.-M.

Cancer Res. 47:4417-4424(1987).

Epidermal growth factor receptor expression and suramin cytotoxicity in vitro.

Milano G.

Eur. J. Cancer 26:867-871(1990).